Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Sarepta snags its partner's CSO, Louise Rodino-Klapac, to lead new gene therapy unit
7 years ago
Celgene CEO Mark Alles poaches a top J&J exec for his senior crew during a C-suite makeover
7 years ago
Ironwood dodges a Denner board seat, but the activist investor still has words of advice
7 years ago
R&D
Novartis loses a head honcho, with US oncology head Bill Hinshaw exiting for new gig at Axcella
7 years ago
Sanofi fires back at Roseanne: 'racism is not a side effect' of Ambien
7 years ago
Arcturus' ex-CEO triumphs, ousting board that ousted him
7 years ago
Top research execs from Teva, Allergan recruited to help lead Axovant out of the R&D wasteland
7 years ago
R&D
Peer Review
Rockwell's CEO refuses to be fired, kicking up brawl with board that halts the company's stock
8 years ago
30-year Gilead R&D vet Norbert Bischofberger is starting over as staffer #5 at an upstart biotech — and he’s loving it
8 years ago
Startups
BD chief George Golumbeski is the latest top exec to exit Celgene during management overhaul
8 years ago
High profile biotech investor Beth Seidenberg is exiting Kleiner Perkins and starting her own fund — report
8 years ago
Financing
Akari CEO Horn Solomon ousted after allegedly abusing the company credit card
8 years ago
Hunting a cure, Ex-Novartis exec Bastiano Sanna takes the reins at Cambridge diabetes startup Semma
8 years ago
Can you cut $600M in R&D costs without slash-and-burn tactics? Andy Plump aims to show us how
8 years ago
R&D
Genentech R&D leader Dietmar Berger moves to Atara Bio, heading up off-the-shelf T cell work
8 years ago
Sarepta CEO Doug Ingram scored a chart-topping $57M compensation deal in 2017. Earning it won’t be easy
8 years ago
‘Biohacker’ Traywick dead at 28 — known for self-injecting a DIY herpes drug
8 years ago
Leena Gandhi steps out of Keytruda spotlight and into a top research job at I/O laggard Eli Lilly
8 years ago
Who’s the top earning CEO in biopharma? Martine Rothblatt once again hits top slot with $37M pay package
8 years ago
Two more top FDA officials hit the exits as an exodus of senior regulators continues
8 years ago
Pharma
Senti scientific co-founder Wilson Wong designs the SUPRA — a new, high performance model CAR-T
8 years ago
Discovery
After decades in the big leagues, Martin Mackay is going small — and he's delighted
8 years ago
Financing
Startups
Arrested and charged with fraud, PixarBio CEO Frank Reynolds could face up to 20 years in prison
8 years ago
Biotech stars Schleifer and Yancopoulos share $52M in 2017 compensation, even though Regeneron's share price swooned
8 years ago
First page
Previous page
87
88
89
90
91
92
93
Next page
Last page